初始癌症分期对静脉血栓栓塞发生率的影响:斯堪的纳维亚血栓与癌症(STAC)队列研究
斯堪的纳维亚血栓与癌症队列纳入144 952名参与者,1993至2012年随访,研究10种实体瘤分期与客观确诊静脉血栓栓塞(VTE)发生率的关系。随访期间共发生335例VTE,其中293例在5年内发生。诊断时癌症越晚期与VTE风险越高相关,但关联强度在不同癌种间差异很大。
要点
- 远处转移与局限期相比,VTE发生率差的癌种间变异大,胰腺癌最高(IRD 187.0×10⁻³人年)。
- 区域扩散与局限期相比,VTE发生率差最高见于子宫癌(IRD 37.6×10⁻³人年)。
- 乳腺癌和前列腺癌区域扩散与局限期的VTE发生率差接近零。
核心结论
- 诊断时癌症越晚期与VTE风险越高相关,但关联强度在不同癌种间差异很大。
研究设计与样本
- 斯堪的纳维亚血栓与癌症队列纳入144 952名参与者,随访时间为1993年至2012年,分析10种实体癌分期与客观确诊VTE发生率。
主要发现
- 整个随访期间共发生335例VTE,其中293例在5年内发生。
- 远处转移与局限期相比,VTE的IRD最高为胰腺癌(IRD 187.0×10⁻³人年;95%CI -6.7至380.8),最低为前列腺癌(IRD 3.7×10⁻³人年;95%CI -7至15.2)。
- 区域扩散与局限期相比,VTE的IRD最高为子宫癌(IRD 37.6×10⁻³人年;95%CI -23.7至99),乳腺癌和前列腺癌的IRD接近零。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Impact of cancer stage on venous thromboembolism (VTE) risk is not well-known in all cancers. The Scandinavian Thrombosis and Cancer Cohort provides person-time data and validated VTEs. Impact of cancer stage on VTE incidence tended to vary with cancer type. Cancer stage may not per se be a risk factor for VTE in all cancer types. SUMMARY: Background Absolute measures of the impact of cancer stage on the incidence of venous thromboembolism (VTE) in patients with distinct cancer types have not been investigated in a large population-based cohort study. Objectives To investigate differences in the incidence rates of objectively confirmed VTE according to the development of cancer in a large population-based cohort study. Cancer type and stage at the time of diagnosis were taken into account. Patients and Methods The Scandinavian Thrombosis and Cancer Cohort includes data regarding cancer types, stages and objectively confirmed VTE diagnoses among 144 952 participants followed from 1993 to 2012. We studied stage-specific incidence rates of VTE, and calculated incidence rate differences (IRDs) for VTE according to stages in patients with 10 types of solid cancer. Results During the entire follow-up, 335 VTEs occurred, of which 293 occurred within 5 years. The IRD of VTE in patients with distant metastasis as compared with those with localized disease indicated large variation depending on cancer type. The highest IRD was observed for pancreatic cancer (IRD of 187.0 × 10-3 person-years [p-y]; 95% confidence interval [CI] - 6.7 to 380.8), and the lowest IRD was observed for prostate cancer (IRD of 3.7 × 10-3 p-y; 95% CI - 7 to 15.2). Regional spread as compared with localized disease also indicated large variation depending on cancer type; the highest IRD was observed for uterine cancer (IRD of 37.6 × 10-3 p-y; 95% CI - 23.7 to 99), and the IRDs for breast and prostate cancer were close to zero. Conclusion More advanced cancer at the time of diagnosis was associated with a higher risk of VTE, but the strength of the associations differed substantially between cancer types.
引用
- Gade IL, Braekkan SK, Naess IA, et al. The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort. J Thromb Haemost. 2017. PMID: 28585779. doi:10.1111/jth.13752
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。